SunCar Technology Group Inc (SDA) Stock News

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who purchased CRMT securities may be eligible for compensation through a class action lawsuit.

Iovance Biotherapeutics approved the grant of inducement stock options covering 140,860 shares to 27 new non-executive employees on June 18, 2026, with an exercise price of $3.91 per share. The options vest over three years under the company's Amended and Restated 2021 Inducement Plan.

The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. after the company filed a late filing notification on March 17, 2026, disclosing material errors in previously issued financial statements for 2023-2025. The errors involved revenue recognition, stock-based compensation, and capitalized software development expenses. TruBridge's stock fell 10.5% on the announcement. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) following an FDA Complete Response Letter on February 13, 2026, regarding its bitopertin program. The FDA stated it could not approve the new drug application due to uncertainties requiring additional evidence. Disc Medicine's stock price fell 22% on the news. The firm is preparing a class action lawsuit to recover investor losses.

Law firm Kessler Topaz Meltzer & Check is investigating Futu Holdings Limited for potential securities law violations following a Reuters report that China would crack down on brokers illegally moving money to foreign markets and penalize online brokers like Futu for soliciting business without proper onshore licenses. Futu's stock price fell over 27% following the news.

The Rosen Law Firm has announced an investigation into potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and gaming quality metrics. The allegations claim patients have suffered and died as a result, causing Ensign shares to fall sharply on June 8, 2026.

A class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) alleging that the company made false and misleading statements regarding its ERAS-0015 drug candidate. The lawsuit claims the preclinical data was based on improper comparisons and lacked reasonable basis. On April 28, 2026, Erasca disclosed a patent infringement letter from Revolution Medicines, causing the stock to plummet 48% from $19.15 to $9.90 per share.

A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) for the period between August 9, 2024 and March 25, 2026. The complaint alleges material misstatements regarding revenues, undisclosed related party transactions, channel stuffing practices, and inadequate internal controls. The stock dropped 29.1% following a Culper Research report exposing these practices on March 24, 2026.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against UP Fintech Holding Limited and Futu Holdings Limited following China's announcement of a crackdown on cross-border securities trading. The regulatory action resulted in UP Fintech's stock falling 25.3% on May 22, 2026, with allegations that the companies issued materially misleading business information to investors.

The Rosen Law Firm announced an investigation into potential securities claims against Futu Holdings Limited (NASDAQ: FUTU) following China's announcement of a major crackdown on cross-border securities trading. The regulatory action, announced on May 22, 2026, targeted online brokers including Futu for allegedly soliciting business without proper onshore licenses. Futu's ADSs fell 27.5% on the news. The firm is preparing a class action lawsuit to recover investor losses.

EyePoint, Inc. granted non-statutory stock options to three new employees as inducement awards on June 15, 2026. The company granted options to purchase 39,700 shares at an exercise price of $12.08 per share with a ten-year term and four-year vesting schedule. The grants were approved by the Compensation Committee in accordance with NASDAQ regulations.

The Rosen Law Firm is investigating potential securities claims against Wise Group plc (NASDAQ: WSE) following a Wall Street Journal report that Brussels' public prosecutor is preparing to summon the payment processor over a money laundering investigation. The stock fell sharply on June 1, 2026 following the news. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Disc Medicine (IRON), TruBridge (TBRG), and PennyMac Financial Services (PFSI) for allegedly issuing materially misleading business information. Disc Medicine's stock fell 22% on February 13, 2026, following an FDA Complete Response Letter rejecting its bitopertin program NDA. Investors who suffered losses are encouraged to join prospective class action lawsuits.

Univest Securities completed an $8 million registered direct offering for Pop Culture Group Co., Ltd (NASDAQ: CPOP), a China-based pop culture company. The offering consisted of approximately 53.3 million Class A ordinary shares or pre-funded warrants at $0.15 per share. Univest acted as the sole placement agent for the transaction.

Rosen Law Firm is investigating potential securities claims against Elauwit Connection, Inc. (NASDAQ: ELWT) following the company's announcement on February 27, 2026, that it must restate previously issued interim financial statements due to errors in network construction project revenue recognition during the first nine months of 2025. The disclosure resulted in a 6.8% stock price decline. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm has launched an investigation into The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations claim patients have suffered and died as a result. Ensign shares fell sharply on June 8, 2026, following the report's publication.

Rosen Law Firm has launched a securities class action investigation against Futu Holdings Limited (NASDAQ: FUTU) following China's announcement of a crackdown on cross-border securities brokers operating without onshore licenses. The news triggered a 27.5% stock price decline on May 22, 2026. Investors who suffered losses are encouraged to join the prospective class action.

A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) for allegedly making material misstatements about the viability of its $51 million acquisition of Fabric Genomics. On May 4, 2026, GeneDx disclosed a $31.3 million impairment loss on Fabric and missed earnings projections, causing the stock to plunge 49%. Investors who purchased WGS stock between April 16, 2025, and May 4, 2026, can seek lead plaintiff status by August 3, 2026.

The Rosen Law Firm is investigating potential securities claims against Wise Group plc (NASDAQ: WSE) following a Wall Street Journal report that Brussels' public prosecutor is preparing to summon the payment processor over a money laundering investigation. The stock fell sharply on June 1, 2026 following the news. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against multiple companies. Disc Medicine (IRON) received an FDA Complete Response Letter on its bitopertin program, causing a 22% stock price decline on February 13, 2026. The firm is also pursuing class action lawsuits against DNOW Inc. and Badger Meter, Inc. on behalf of affected shareholders.

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of UP Fintech Holding Limited following China's announced crackdown on cross-border securities trading. The regulatory action caused UP Fintech's stock to plummet 25.3% on May 22, 2026. The firm is also investigating similar claims against DNOW Inc. and Badger Meter, Inc.

Rosen Law Firm is investigating potential securities claims against Elauwit Connection, Inc. (NASDAQ: ELWT) for allegedly issuing materially misleading business information. The company filed an 8-K on February 27, 2026, announcing non-reliance on previously issued interim financial statements due to errors in network construction project revenue recognition during the first nine months of 2025. Following this disclosure, ELWT's stock price fell $0.52 per share (6.8%) to $7.12 on March 2, 2026. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm announced an investigation into potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and gaming quality metrics. The allegations claim patients have suffered and died as a result, and that profits depend on routing taxpayer dollars to executives and affiliates. Ensign shares fell sharply on June 8, 2026 following the report's publication.

Lowey Dannenberg P.C. has been appointed co-lead counsel in a class action lawsuit against Ramaco Resources Inc. alleging violations of federal securities laws related to the company's July 2025 senior notes offering. Investors who purchased common stock in connection with the offering may be eligible to recover losses and must act before June 22, 2026.

Johnson Fistel, PLLC is investigating Datavault AI Inc. (NASDAQ: DVLT) following a Wolfpack Research short report alleging the company engaged in stock promotion with misleading press releases about AI, quantum computing, and Web 3.0. The report questioned the company's actual business operations and claimed its blockchain marketplace had virtually no trading activity. Datavault's stock price declined following the allegations, and the law firm is investigating potential federal securities law violations.

Johnson Fistel, PLLP is investigating Portillo's Inc. (NASDAQ: PTLO) for potential federal securities law violations following the company's significant downward revisions to its fiscal 2025 guidance in August and September 2025. The company reduced revenue growth targets, lowered same-restaurant sales outlook from 1-3% growth to 1-1.5% decline, cut unit-growth targets from 12 to 8 new restaurants, and reduced adjusted EBITDA expectations. These disclosures resulted in a sharp decline in Portillo's stock price, prompting the investigation into whether the company complied with federal securities laws.

The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. after the company disclosed material errors in its previously issued financial statements for fiscal years 2023-2025. The errors relate to revenue recognition, stock-based compensation, and capitalized software development expenses. Following the announcement on March 17, 2026, TruBridge's stock fell 10.5% to $15.75 per share. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Disc Medicine (IRON), TruBridge (TBRG), and Graphic Packaging Holding Company (GPK) for allegedly issuing materially misleading business information. Disc Medicine's stock fell 22% following an FDA Complete Response Letter on its bitopertin program in February 2026.

The Rosen Law Firm is investigating potential securities claims against Blaize Holdings, Inc. (NASDAQ: BZAI) following allegations of materially misleading business information. A short seller report alleged the company's $50 million NeoTensr deal was fraudulent, causing BZAI stock to fall 12% on April 28, 2026. The firm is preparing a class action lawsuit to recover investor losses.